https://www.selleckchem.com/pr....oducts/gf109203x.htm
Background Rhizoma Anemarrhenae (RA) has been conventionally used for treatment of Alzheimer's disease (AD) in Traditional Chinese Medicine, and thus, the active components from RA can be screened. Purpose This research aimed to identify the active components of RA and their targets and further clarify the molecular mechanisms underlying its anti-AD activity. Methods First, the potential active compounds from RA were screened by neurocyte extraction and micro-dialysis methods. Second, the potential targets were predicted by a chemogen
Like
Comment
Share
